Schedule 13D ownership disclosure
CEREVEL THERAPEUTICS HLDNG I
Security class unavailable · CUSIP: 15678U128
Event date: 2023-04-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-23-114928
- Form type
- SC 13D
- Filer
- Cerevel Therapeutics Holdings, Inc.
- CIK
- CIK 1805387
- Filed
- Apr 25, 2023
- Reporting period
- Apr 25, 2023
- Description
- Schedule 13D beneficial ownership